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Abstract 
Background: The treatment of ischemic heart disease has advanced substantially in the past 
half-century. However, despite these achievements, the survival rates in high-income countries 
such as Sweden have reached a plateau in the last decade. Strategies to further reduce mortality 
are needed. 
Aims: To evaluate the impact of chronic total occlusions, the choice of arterial access site, and 
pretreatment with P2Y12 inhibitors on mortality in patients with coronary artery disease.  
Methods: This thesis is based on observational studies. We used data from the Swedish Web-
system for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated 
According to Recommended Therapies (SWEDEHEART) registry and the Swedish National 
Cause of Death Register. All coronary procedures, angiographies and percutaneous coronary 
interventions (PCIs) performed in Sweden are registered in the SWEDEHEART registry. We used 
multiple imputation to impute missing data (Papers I–IV), propensity score (PS) matching to 
adjust for known confounders (Papers II, IV), multilevel models to account for a hierarchical 
database (Paper II, III, IV), and instrumental variable analysis to adjust for known and unknown 
confounders (Paper III). 
Results: In Paper I, we found an adjusted hazard ratio (HR) of 1.29 for death in patients with a 
chronic total occlusion (CTO), as compared to patients with coronary artery disease without a 
CTO. In Paper 2, pretreatment was not associated with better 30-day survival or differences in 
bleeding in STEMI patients. In Paper 3, pretreatment in NSTE-ACS patients was not associated 
with better 30-day survival but with a higher risk of in-hospital bleeding. In Paper IV, we could 
show that radial access (RA) in patients undergoing primary PCI for STEMI was associated with 
a lower risk of death (adjusted odds ratio (OR) 0.70) within 30 days, as compared to femoral 
access (FA).  
Conclusion: The CTOs of coronary arteries are associated with increased mortality. Pretreatment 
with P2Y12 receptor antagonists is not associated with reduced mortality in patients with acute 
coronary syndrome, but is associated with increased in-hospital bleeding in NSTE-ACS patients. 
Our findings in Paper II and III add external validity to the findings of randomized trials on the 
lack of benefits and potential harms of pretreatment. The use of radial artery access for primary 
PCI in STEMI is associated with reduced mortality in comparison to using FA. The findings in 
Paper IV support the ESC guideline recommendation for the use of RA in STEMI.  
